IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview
J Inflamm Res
.
2023 Mar 21:16:1209-1212.
doi: 10.2147/JIR.S397749.
eCollection 2023.
Authors
Mohammed Safi
#
1
,
Al-Shaebi Fadhl
#
1
,
Yousif A Algabri
2
,
Caiqing Zhang
1
Affiliations
1
Department of Respiratory Diseases, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, People's Republic of China.
2
Department of Biomedical Engineering, School of Control Science and Engineering, Shandong University, Jinan, Shandong, People's Republic of China.
#
Contributed equally.
PMID:
36974205
PMCID:
PMC10039624
DOI:
10.2147/JIR.S397749
No abstract available
Grants and funding
This research was funded by the National Natural Science Foundation of China, Grant/Award Number: 62271292.